Our finding might be more clinically relevant because MYBL2 has been used as aggressive prognostic marker for breast cancer24, and its expression, reflected by a functional SNP rs619289, significantly modifies breast cancer risk and predicts a poor outcome. This evidence concerns the gene MYBL2 and breast carcinoma.